Spring 2027

The Drug Development Process From Discovery to Investigational New Drug Application (ind)

Overview of drug development from discovery to IND, covering target identification, validation, hit-to-lead, CMC, pharmacology, pharmacokinetics, and toxicology for small and large molecules.

offering recorded3 credits
Recorded instructors · Spring 2027 Ardala KatzfussLeslie Dickmann

Summary

1 / 3

Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades).

What you’ll be able to do

  • Describe the phases of drug development from target discovery to investigational new drug (IND) submission and the different functional areas involved.

  • Explain how target pharmacology and drug safety are assessed using both in vitro and in vivo preclinical models.

  • Explain the chemistry, manufacturing, and controls (CMC) activities that take place during discovery and preclinical development.

  • Apply the knowledge learned throughout the course to address specific drug development challenges and propose novel solutions.

  • Evaluate how preclinical development might differ between small molecule drugs and protein therapeutics.

  • Create a preclinical drug development strategy for a specific drug modality and disease combination.

Source: UW Guide

Grade history

↗
average GPA
letter grades
A
AB
B
BC
C
D
F

All recorded terms · compare terms & instructors

Prerequisites

Course map

Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development

  • Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development
PHMSCI 762 used by

“Used by” includes alternatives; linked courses may have other requirements. This is a best-effort interpretation; check the catalog requirements above.

Prerequisite text tree
  • Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development

Professors

Spring 2027

Recent recorded grades — Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades). Includes jointly taught sections.

Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades). Includes jointly taught sections.

Historical instructors & teaching patterns

ARDALA KATZFUSS is recorded teaching in Spring 2026. Recorded history may be incomplete and does not establish a future schedule.

LESLIE DICKMANN is recorded teaching in Fall 2023, Fall 2024, Spring 2025, Fall 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.

Recorded history may be incomplete and does not establish a future schedule.

Calendar & sections

Spring 2027

Schedule loads here as you scroll.

SectionModeEnrolled / capacityWaitlist
LEC 001Online Only0 / 250
LEC 002Online (some classroom)0 / 50

Times are Central. Select a meeting for details; export includes recorded dates for the selected sections. Enrollment reflects scan time.

Meeting source records
Download part 1

Student experience

the class

Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades).

difficulty & workload

No workload feedback recorded.

Topics

  • Drug discovery including target identification, target validation, and hit-to-lead.
  • Preclinical chemistry, manufacturing, and controls (CMC) activities.
  • Preclinical pharmacology, pharmacokinetic, and toxicology studies.
  • Application to small and large molecule drugs.

Skills

  • Describing phases of drug development from target discovery to IND submission and identifying involved functional areas.
  • Explaining assessment of target pharmacology and drug safety using in vitro and in vivo preclinical models.
  • Explaining chemistry, manufacturing, and controls (CMC) activities during discovery and preclinical development.
  • Evaluating differences in preclinical development between small molecule drugs and protein therapeutics.
  • Creating a preclinical drug development strategy for a specific drug modality and disease combination.

Grades

Latest available · Spring 2026— not enough history to project Spring 2027.

average GPA
A / AB grades
letter grades
Instructor

Grade distribution · % of letter grades

A
AB
B
BC
C
D
F

Grades over time

Through Spring 2026

More grade details Grade mix, volume & source data

Not enough comparable courses for Spring 2027 in UW–Madison.

Sources & history

UW–Madison

Catalog & offerings

Descriptions, prerequisites, and recorded course offerings.

Catalog observation history

Observations at scan time; dates do not imply when a catalog change took effect.

Download part 1
Selected offering source records
PHMSCI 762 · Spring 2027

The Drug Development Process from Discovery to Investigational New Drug Application (IND)

Recorded 2026-10-14
Raw records 
[
  {
    "run_id": "20261014T203208-0851c9a1",
    "semester": "1274",
    "observed_at": "2026-10-14 17:50:09.728220+00:00",
    "offering_id": "1274:718:026563",
    "course_id": "PHMSCI 762",
    "course_uid": "course_1d5bb2f15f5fd3f6e4e8f809",
    "term_id": "1274",
    "source_course_id": "026563",
    "source_subject_id": "718",
    "title": "The Drug Development Process from Discovery to Investigational New Drug Application (IND)",
    "credits_min": 3,
    "credits_max": 3,
    "typically_offered": "Not Applicable"
  }
]
Rate My Professors

Student reviews

Original comments behind the course and instructor summaries.

Read original reviews

No records available.

Madgrades

Grade history

Recorded grade distributions by term, section, and instructor.

Explore recorded grades
Dataset & model

Recorded 2026-10-14

View the dataset on Hugging Face
Model outputs & technical records
Qwen/Qwen3.8-27B
LLM outputs across runs
Download part 1
Full model traces

Recorded model configuration, reasoning, and tool conversations.

Download part 1
Model & dataset provenance 
{
  "model": "Qwen/Qwen3.8-27B",
  "model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
  "task_version": "17",
  "output_id": "5dc6fb46e07ca6f7bdee0080ebec4b28446ebea332a8959835839d507f043e73",
  "requirements_status": "needs_review",
  "dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
  "observed_at": "2026-10-14 17:50:09.728220+00:00"
}